SATOH; Motohide

Patent Applications and Registrations

Patent applications and USPTO patent grants for SATOH; Motohide.The latest application filed is for "stable crystal of 4-oxoquinoline compound".

Company Profile

2.6.15

SATOH; Motohide - Osaka JP
SATOH; Motohide - Takatsuki-shi JP
Satoh; Motohide - Takatsuki JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stable Crystal Of 4-oxoquinoline Compound App 20220235009 - SATOH; Motohide ; et al.	2022-07-28
4-oxoquinoline Compound And Use Thereof As Pharmaceutical Agent App 20200101061 - Satoh; Motohide ; et al.	2020-04-02
Stable Crystal Of 4-oxoquinoline Compound App 20190185433 - SATOH; Motohide ; et al.	2019-06-20
Stable Crystal Of 4-oxoquinoline Compound App 20180029989 - SATOH; Motohide ; et al.	2018-02-01
Stable Crystal Of 4-oxoquinoline Compound App 20150361044 - SATOH; Motohide ; et al.	2015-12-17
4-oxoquinoline Compound And Use Thereof As Pharmaceutical Agent App 20150174117 - SATOH; Motohide ; et al.	2015-06-25
4-oxoquinoline Compound And Use Thereof As Hiv Integrase Inhibitor App 20130172344 - SATOH; Motohide ; et al.	2013-07-04
4-oxoquinoline compound and use thereof as HIV integrase inhibitor Grant 8,232,401 - Satoh , et al. July 31, 2	2012-07-31
6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor Grant 7,872,004 - Satoh , et al. January 18, 2	2011-01-18
Stable Crystal Of 4-oxoquinoline Compound App 20100204271 - SATOH; MOTOHIDE ; et al.	2010-08-12
Quinolizinone compound and use thereof as HIV integrase inhibitor Grant 7,745,459 - Satoh , et al. June 29, 2	2010-06-29
Stable crystal of 4-oxoquinoline compound Grant 7,635,704 - Satoh , et al. December 22, 2	2009-12-22
4-oxoquinoline compound and use thereof as HIV integrase inhibitor Grant 7,531,554 - Satoh , et al. May 12, 2	2009-05-12
6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor App 20080207618 - SATOH; Motohide ; et al.	2008-08-28
4-oxoquinoline compound and use thereof as pharmaceutical agent Grant 7,176,220 - Satoh , et al. February 13, 2	2007-02-13
4-Oxoquinoline compound and use thereof as HIV integrase inhibitor App 20060217413 - Satoh; Motohide ; et al.	2006-09-28
Quinolizinone compound and use thereof as HIV integrase inhibitor App 20060084665 - Satoh; Motohide ; et al.	2006-04-20
Stable crystal of 4-oxoquinoline compound App 20060030710 - Satoh; Motohide ; et al.	2006-02-09
Novel 4-oxoquinoline compound and use thereof as HIV integrase inhibitor App 20060019906 - Satoh; Motohide ; et al.	2006-01-26
4-Oxoquinoline compounds and utilization thereof as hiv integrase inhibitors App 20050239819 - Satoh, Motohide ; et al.	2005-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.